Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

continued:

Alzheimer's treatments: What's on the horizon?

Antibiotics

A three-month course of antibiotics, specifically doxycycline and rifampin, reduced the rate at which cognitive problems worsened in a group of people who had mild to moderate Alzheimer's disease. The antibiotics appear to interfere with the development of amyloid plaques in the brain.

Hormones

Early studies indicated that hormone replacement therapy, typically prescribed to ease menopausal symptoms, might protect women over the age of 65 against Alzheimer's. But more recent studies not only refute these findings but also suggest that this hormone therapy might even increase the risk of dementia.

The timing of the hormone replacement therapy may be the reason for apparently contradictory results. Some researchers speculate that early hormone therapy, during a woman's 50s, may be protective, while later use becomes harmful.

In men, low testosterone levels have been linked to increased risk of Alzheimer's disease. Researchers are investigating whether testosterone supplements might help men who have Alzheimer's or are at risk of the disease, but the results have been mixed.

Timeline for answers

New Alzheimer's treatments take time to develop, and then even more studies are needed to establish a treatment's safety and effectiveness. But all this time and effort will eventually pay off. Most researchers expect to see major progress in the treatment and prevention of Alzheimer's in the next few decades.

Previous page
(2 of 2)
References
  1. Alzheimer's Treatment. National Institute on Aging. http://www.nia.nih.gov/Alzheimers/AlzheimersInformation/Treatment/. Accessed July 16, 2008.
  2. Press D, et al. Treatment of dementia. http://www.uptodate.com/home/index.html. Accessed July 16, 2008.
  3. Salloway S. Taking the next steps in the treatment of Alzheimer's disease: Disease-modifying agents. CNS Spectrums. 2008;(3)(suppl):11-14.
  4. Press D, et al. Future directions in dementia treatments. http://www.uptodate.com/home/index.html. Accessed July 16, 2008.
  5. Holmes C, et al. Long-term effects of amyloid beta immunization in Alzheimer's disease: Follow-up of a randomized, placebo-controlled phase I trial. The Lancet 2008;372(9634):216-223.
  6. Shah SS, et al. Current approaches in the treatment of Alzheimer's disease. Biomedicine and Pharmacotherapy. 2008;62(4):199-207.
  7. 2007: The year in Alzheimer science. Alzheimer's Association. http://www.alz.org/alzheimers_disease_research_ad.asp. Accessed July 21, 2008.
  8. Van Marum RJ. Current and future therapy in Alzheimer's disease. Fundamental and Clinical Pharmacology. 2008;22(3):265-274.
  9. Grodstein F. Estrogen and cognitive function. http://www.uptodate.com/home/index.html. Accessed July 22, 2008.

AZ00048

Oct. 4, 2008

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger